Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Orchestra BioMed Holdings, Inc.
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Nasdaq · Surgical & Medical Instruments & Apparatus
Prev close 6.04 · gapped above the open, then crossed back over prior close. High/low 6.16 at 9:30 am ET, 5.95 at 10:45 am ET.
Each disclosed tie as a share of both companies’ annual revenue. The bigger share is the side that would feel it if the relationship ended.
| Partner | % of their revenue | % of OBIO revenue | Skew |
|---|---|---|---|
| LGNDLigand Pharmaceuticals Incorporated ("Ligand") | 2.12% | 17.00% | 8.0× |
Sources
sec edgar · verbatim disclosureEach tie, with the sentence that disclosed it. Open a row for the wording and the filing it came from.
“In repayment of the Investment Amount, we will remit 17.0% of revenues related to the Products until an annual total of $17.0 million has been remitted to Ligand, thereafter we will remit (a) 4.0% of revenues related to the Primary Product in the field of hypertension treatment and (b) 4.0% of revenues related to the Secondary Product in the field of coronary artery treatment.”
$6M relationship8.0× more of OBIO’s book than LGND’s
basisOBIO fy2025 · closed 2025-12 $33MLGND fy2025 · closed 2025-12 $268M
FILING10-K0001104659-26-026754cik 0001814114
“The Moderato system, comprised of the implantable pulse generator ("IPG") and programmer, was manufactured under an original equipment manufacturer contract by a division of Integer Holdings Corporation ("Integer"), a leading supplier of cardiac rhythm management device components.”
FILING10-K0001104659-26-026754cik 0001814114
“Medtronic is also providing clinical, regulatory, operational field clinical resources in support of the BACKBEAT study.”
FILING10-K0001104659-26-026754cik 0001814114
“Currently, the workstation component of our Pure-Vu® System is manufactured by Sanmina Corporation at their facilities in Israel.”
FILING10-K0001104659-26-026754cik 0001814114
“In addition, we concluded that Medtronic is a customer for a good or service that is a distinct unit of account, and therefore, the transact ions in the Medtronic Agreement, as amended pursuant to the Medtronic Agreement Amendment (the "Amended Medtronic Agreement"), should be accounted for under ASC 606.”
FILING10-K0001104659-26-026754cik 0001814114
“The Termination and ROFR Agreement, which supersedes and terminates the prior Virtue SAB distribution agreement between us and Terumo (the "Terumo Agreement"), grants Terumo a right of first refusal ("ROFR") to acquire the rights, or enter a distribution arrangement, with respect to Virtue SAB for the treatment of coronary artery disease, in exchange for an upfront payment of $10.0 million.”
FILING10-K0001104659-26-026754cik 0001814114
“In February 2023, we also contracted with MEDICO S.R.L. to develop a dual chamber pacemaker device that meets our specifications for running our cardiac neuromodulation therapies as well as standard pacing algorithms.”
FILING10-K0001104659-26-026754cik 0001814114
“The disposable portion of the Pure-Vu EVS is manufactured by Sterling Industries in their Michigan, U.S. facility.”
FILING10-K0001104659-26-026754cik 0001814114
“The Termination and ROFR Agreement, which supersedes and terminates the prior Virtue SAB distribution agreement between us and Terumo (the "Terumo Agreement"), grants Terumo a right of first refusal ("ROFR") to acquire the rights, or enter a distribution arrangement, with respect to Virtue SAB for the treatment of coronary artery disease, in exchange for an upfront payment of $10.0 million.”
FILING10-K0001104659-26-026754cik 0001814114
“The Termination and ROFR Agreement, which supersedes and terminates the prior Virtue SAB distribution agreement between us and Terumo (the "Terumo Agreement"), grants Terumo a right of first refusal ("ROFR") to acquire the rights, or enter a distribution arrangement, with respect to Virtue SAB for the treatment of coronary artery disease, in exchange for an upfront payment of $10.0 million.”
FILING10-K0001104659-26-026754cik 0001814114
Watchlist prices, news filtered to it, and its next report on your desk.
Orchestra BioMed Holdings, Inc. has 5 disclosed suppliers and 5 disclosed customers. Each one is named in an SEC filing, either Orchestra BioMed Holdings, Inc.’s own annual report or the counterparty’s, and carries the sentence that discloses it.
OBIO (Orchestra BioMed Holdings, Inc.) has 5 disclosed suppliers and 5 disclosed customers, strongest disclosure first.
Suppliers:
Customers:
Select a tie for the filing sentence that discloses it; select again to open the company. Lines are disclosed suppliers and customers, coloured by industry; the closer to the centre, the more the filings disclose. A dot is green or red by today’s move. Extended: satellites hang off single companies, not bundled sectors.
Largest move on the map today: SANM −2.68%, in semiconductor.